Proteomics

Dataset Information

0

Serum Metabolomics in Patients with Ocular Diseases


ABSTRACT: Serum metabolomics in patients with ocular diseases is a fascinating and emerging field of study. It involves analyzing the metabolites in blood serum to understand the biochemical processes and pathways associated with various eye conditions. This approach provides a deeper insight into the pathophysiology of ocular diseases and can lead to novel diagnostic and therapeutic strategies.

ORGANISM(S): Homo Sapiens

SUBMITTER: Wenjun Cao  

PROVIDER: PXD048826 | iProX | Wed Jan 24 00:00:00 GMT 2024

REPOSITORIES: iProX

altmetric image

Publications

Metabolomics identifies and validates serum androstenedione as novel biomarker for diagnosing primary angle closure glaucoma and predicting the visual field progression.

Li Shengjie S   Ren Jun J   Jiang Zhendong Z   Qiu Yichao Y   Shao Mingxi M   Li Yingzhu Y   Wu Jianing J   Song Yunxiao Y   Sun Xinghuai X   Gao Shunxiang S   Cao Wenjun W  

eLife 20240215


<h4>Background</h4>Primary angle closure glaucoma (PACG) is the leading cause of irreversible blindness in Asia, and no reliable, effective diagnostic, and predictive biomarkers are used in clinical routines. A growing body of evidence shows metabolic alterations in patients with glaucoma. We aimed to develop and validate potential metabolite biomarkers to diagnose and predict the visual field progression of PACG.<h4>Methods</h4>Here, we used a five-phase (discovery phase, validation phase 1, va  ...[more]

Similar Datasets

2017-05-02 | E-GEOD-57362 | biostudies-arrayexpress
2017-05-02 | GSE57362 | GEO
2024-10-04 | PXD054459 | Pride
2016-08-01 | E-GEOD-81254 | biostudies-arrayexpress
2023-11-16 | MTBLS8943 | MetaboLights
2016-08-01 | GSE81254 | GEO
2011-03-02 | E-GEOD-27593 | biostudies-arrayexpress
2019-06-04 | GSE129479 | GEO
2021-06-25 | GSE178833 | GEO
2020-01-09 | PXD015362 | Pride